Rat Model Market Size & Share, By Type (Outbred, Knockout), Technology (Embryonic Stem Cell, Microinjection), Service, Application, End-use, Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Market Outlook:

Rat Model Market was over USD 1.52 Billion in 2023 and is expected to exceed USD 2.84 Billion by end of the year 2032, observing around 7.2% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 1.52 Billion
• CAGR (2024-2032): 7.2%
• Forecast Year Value (2032): USD 2.84 Billion
• Historical Data Period: 2019-2023
• Largest Region: North America
• Forecast Period: 2024-2032

Market Dynamics:

Growth Drivers & Opportunity:

Increasing demand for personalized medicine and advancements in genetic engineering technologies are expected to drive the growth of the rat model market. Additionally, rising prevalence of chronic diseases and the need for more accurate and reliable preclinical models are significant growth drivers for the market. Furthermore, the growing focus on developing new therapies for various diseases is creating lucrative opportunities for market players in the rat model industry.

Report Scope

Report Coverage	Details
Segments Covered	Type, Technology, Service, Application, End-Use
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	Charles River Laboratories, genOway, TransViragen,, Laboratory of America Holdings, Janvier Labs, Taconic Biosciences,, Biomere, Cyagen Biosciences

Industry Restraints:

The stringent regulations and ethical concerns regarding the use of animals in research could restrain the growth of the rat model market. Moreover, the high cost of maintenance and housing of rats, as well as the lack of standardization in experimental procedures, are major restraints that could hinder market growth in the coming years.

Regional Forecast:

North America:

The North America rat model market is expected to experience significant growth due to the presence of leading research institutions and pharmaceutical companies in countries such as the U.S. and Canada. The increasing focus on drug discovery and development, along with the rising investments in research activities, are driving the demand for rat models in the region.

2. Asia Pacific:

In the Asia Pacific region, countries such as China, Japan, and South Korea are witnessing a growing adoption of rat models in biomedical research. The increasing prevalence of chronic diseases and the rising investments in healthcare infrastructure are propelling the demand for rat models in this region. Additionally, the presence of key market players and academic research institutes is further boosting the market growth.

3. Europe:

Europe, particularly in countries like the United Kingdom, Germany, and France, is projected to witness steady growth in the rat model market. The region is characterized by a strong presence of pharmaceutical and biotechnology companies, along with well-established research facilities and academic institutions. The increasing focus on personalized medicine and the growing investments in biomedical research are driving the demand for rat models in Europe.

Segmentation Analysis:

In terms of segmentation, the global Rat Model market is analyzed on the basis of Type, Technology, Service, Application, End-Use.

Type:

The rat model market can be segmented based on type into outbred and knockout models. Outbred models are genetically diverse and are often used in toxicology studies and pharmacokinetics research. On the other hand, knockout models have specific genes inactivated to study the function of those genes and their role in diseases. Knockout models are extensively used in research related to cancer, cardiovascular diseases, and neurological disorders.

Technology:

In terms of technology, the rat model market can be divided into two categories embryonic stem cell technology and microinjection technology. Embryonic stem cell technology involves the manipulation of embryonic stem cells to create genetically modified rat models. This technology allows for precise gene targeting and the creation of models with specific mutations. Microinjection technology, on the other hand, involves the direct injection of DNA into the pronuclei of fertilized embryos to produce transgenic rat models. This technology is commonly used to introduce foreign genes into rat embryos for the study of gene function and disease modeling.

Service:

The rat model market can also be segmented based on the services offered, such as breeding services, cryopreservation services, genotyping services, and phenotyping services. Breeding services involve the maintenance and propagation of rat colonies for research purposes. Cryopreservation services allow for the storage of genetically modified rat models for future use. Genotyping services help researchers identify specific genetic mutations in rat models, while phenotyping services involve the characterization of physical and behavioral traits in rat models.

Application:

In terms of application, the rat model market can be categorized into drug development, toxicology testing, physiology research, and behavioral studies. Rat models are commonly used in drug development studies to assess the efficacy and safety of new pharmacological compounds. They are also used in toxicology testing to evaluate the potential adverse effects of chemicals and drugs. In physiology research, rat models are employed to study various biological processes such as metabolism, reproduction, and immune responses. Behavioral studies using rat models are conducted to investigate mental health disorders, addiction, and learning and memory processes.

End-use:

Finally, the rat model market can be segmented based on end-use into academic research institutions, pharmaceutical companies, contract research organizations (CROs), and biotechnology companies. Academic research institutions use rat models for basic research and to study disease mechanisms. Pharmaceutical companies utilize rat models in drug discovery and preclinical testing. CROs offer rat model services to facilitate research and development activities for pharmaceutical and biotechnology companies. Biotechnology companies use rat models for the development of new therapies and diagnostic tools.

Competitive Landscape:

The competitive landscape in the Rat Model Market is characterized by a variety of players engaged in providing genetically standardized and disease-specific rat models for research purposes. Companies are focusing on innovation and customization to meet the growing demands of drug discovery, toxicology studies, and genetic research. Strategic collaborations, mergers, and acquisitions are common as firms seek to expand their product portfolios and enhance their market presence. The increasing prevalence of chronic diseases and the subsequent rise in biomedical research are driving competition. Furthermore, advancements in genetic engineering, such as CRISPR technology, have intensified the race among companies to offer novel and more accurate models that can accurately mimic human diseases.

Top Market Players

- Charles River Laboratories

- Jackson Laboratory

- Envigo

- Taconic Biosciences

- Horizon Discovery

- GenOway

- The Jackson Laboratory

- StriMark

- BioIVT

- Inotiv